Dr. Randeep Singh 
Head of Department (HOD)
28 Years of ExperienceMedical Oncologist
MBBS, MD, DM, FCCP
Reg. No.:32096, Delhi Medical Council
Dharamshila Narayana Superspeciality Hospital, New Delhi
English, Hindi, Punjabi
Consultation Fee ₹ 2000
Book an AppointmentAbout Dr. Randeep Singh
- Dr. Randeep Singh is a renowned and experienced medical oncologist in Delhi with an impressive experience of 28 years.
- He is trained and well-versed in dealing with solid and hematolymphoid tumors. He also specializes in different types of chemotherapy while providing precision oncology-based treatment.
- Dr. Randeep Singh has vast experience with patients affected with cancer in the lungs, blood, breast, gastrointestinal tract, liver, pancreas, bile duct, and genitourinary tract.
- He has expertise in offering cancerous treatments like
- Target Therapy
- Immunotherapy
- Hormone Therapy
- Biotherapy
- Precision Oncology
- Dr. Randeep Singh did an MBBS from Bharati Vidyapeeth Deemed University in 1996, and his specialization was DM in Medical Oncology at Tata Memorial Centre in 2008.
- He also earned an MD in Pediatrics from S.N. Medical College, Jodhpur, Rajasthan University, in 2003.
- Dr. Singh has been certified by the European Certified Medical Oncology (ECMO) and is a Fellow American Chest Physicians (FCCP).
- He has been an active participant in quizzes where he won first and second positions. Further, he has multiple published papers.
- Dr. Singh is associated with numerous organizations and is editor-in-chief of research journals.
Book Your Appointment With Dr. Randeep Singh
Get a Treatment Plan Within 1 Hour
Education
- MBBS - Bharati Vidyapeeth Deemed University, 1996
- MD - Pediatrics - S.N. Medical College, Jodhpur, Rajasthan University, 2003
- DM - Medical Oncology - Tata Memorial Centre, 2008
- Fellow American Chest Physicians (FCCP)
Training & Certificates
- European Certified Medical Oncology (ECMO)
Past Experience
- Senior Consultant and Unit Head Medical Oncology at Artemis Hospital, Gururgram
- Department of Medical Oncology at HCG Cancer Center, Delhi
- Consultant Medical Oncologist at Max Group of Hospitals, Patparganj, 2015
- Consultant Medical Oncologist at Tata Memorial Hospital, Mumbai, 2012
- Senior Resident in Tata Memorial Hospital, 2011
- Senior Residency in Pediatrics at PGIMER, Chandigarh
Awards
- Second Position in Geriatric Oncology Case presentation from the Indian Cooperative Oncology Network in 2014
- Second Position in Hematology Quiz at the National Level from Mumbai Hematology Group in 2011
- First Position in Neonatology quiz at State Level from National Neonatology in 2006
- First Position in Post-Graduate Quiz from Indian Academy Pediatrics at the State Level in 2006
- Second Position in Paper Presentation from Indian Academy Pediatrics at State Levels in 2006
- Received Distinction in Biochemistry, Surgery, and Ophthalmology from BVDU, Pune, during MBBS in 2000
Associations/Membership
- International CME ORG
- Indian Cooperative Oncology Network (ICON)
- Delhi Oncology Forum
- Indian Society of Medical & Pediatric Oncology (ISMPO)
- Indian Academy of Pediatrics (IAP)
- European Society of Medical Oncology (ESMO)
- American Society of Clinical Oncology (ASCO)
Paper Published
- Parikh, P., Babu, G., Singh, R., Krishna, V., Bhatt, A., Bansal, I., ... & Rath, G. K. (2023). Consensus guidelines for the management of HR-positive HER2/neu negative early breast cancer in India, SAARC region and other LMIC by DELPHI survey method. BMC cancer, 23(1), 714.
- Parikh, P. M., & Singh, R. (2020). Why should we rely only on molecular tests based on Indian data? Int J Mol Immuno Oncol, 5, 44-46.
- Parikh, P., & Singh, R. (2021). Hot race for COVID-19 vaccines–light at the end of the tunnel just got brighter. International Journal of Molecular and Immuno Oncology, 6(1), 1-3.
- Parikh, P., Kapoor, A., Joshi, K., Bansal, I., Krishna, V., Sahoo, T. P., ... & Babu, K. G. (2021). Advanced lung cancer and molecular testing in the middle of coronavirus disease 2019 second wave in the South Asian Association for Regional Cooperation Region. International Journal of Molecular & Immuno Oncology, 6(2), 61–65.
- Singh, R., & Gupta, S. (2018). Small HER2 positive breast cancer: When is enough? Indian Journal of Medical and Paediatric Oncology, 39(01), 1–3.
- Singh, R., & Rohtagi, N. (2017). Clinicopathological and molecular epidemiological study of lung cancer patients seen at a tertiary care hospital in Northern India. South Asian Journal of Cancer, 6(04), 171-175.
- Singh, R., Shirali, R., Chatterjee, S., Adhana, A., & Arora, R. S. (2016). Epidemiology of cancers among adolescents and young adults from a tertiary cancer center in Delhi. Indian Journal of Medical and Paediatric Oncology, 37(02), 90–94.
Field of Expertise
- Adrenal Cancer Treatment
- Bacillus Calmette Guerin (BCG) Therapy
- Benign and Cancerous Tumor Excision
- Bile Duct Cancer Treatment
- Bone Marrow Transplant
- Brain Tumor Surgery
Best Oncology Doctors in India
Dr. Ashok Kumar Vaid
Chairman
Medical Oncologist
Medanta - The Medicity Hospital, Gurgaon
Book an Appointment Talk To Expert
Dr. Satya Pal Kataria
Vice Chairman
Medical Oncologist
Medanta - The Medicity Hospital, Gurgaon
Book an Appointment Talk To Expert
Dr. Chandragouda Dodagoudar
Director
Medical Oncologist
BLK-Max Super Speciality Hospital, New Delhi
Book an Appointment Talk To Expert
Dr. Kunjahari Medhi
Senior Director
Medical Oncologist
Medanta - The Medicity Hospital, Gurgaon
Book an Appointment Talk To Expert